Supporting the Journey to Sustainability

Today, the global focus of industry is increasingly on sustainability in all its diverse forms. For the pharmaceutical sector and its supply chains, however, regulatory requirements often add an extra layer of complexity when turning goals into actions.

The determination to drive meaningful change has brought together three pioneering players, united by a shared mission: to transform bio-based raw materials into sustainable medical products. 

With the visionary attitude of elm-plastic GmbH, a Germany-based manufacturer of pharma medical devices, the workstream “bio pipette” is successfully launching the first commercially available bio-product on the market – ready to make a tangible impact on pharma corporate and sustainability goals.

You want to know more on this innovation, on bioplastics and on the impact to GHG?  Any question is welcome. 

Contact Us: elmplastic or meet elmplastic and the expert team at 
CPHI, booth #8.0B30 on October 29 from 10 – 11 am for a Q&A Session to sustainability in pharma medical devices. 

Follow elmplastic on LinkedIn to stay updated with our latest insights and company developments.